The SeroDop Theory
Join me in a journey to reclassify Mental Health Disorders based on an initial two-axis map incorporating dopaminergic and serotonergic systems to enhance pharmacological interventions
A randomized, double-blind, placebo-controlled trial investigating the effect of methylphenidate on Patient Health Questionnaire-9 (PHQ9) responses in patients with Major Depressive Disorder (MDD)
If you are a clinician, an academic supervisor or have general interest in partnering in this study fill the form on this page.
Neurobiological alternative for DSM-5
Implementing a neurobiological framework for classifying mental health disorders, such as major depressive disorder (MDD), generalized anxiety disorder (GAD), and attention deficit disorder (ADD), offers significant potential for tailored pharmacological interventions.